Exogene Corp. hopes to halve the manufacturing costs of therapeutics produced through fermentation, by coupling agroprocessing technology with its pharmacologically active molecules.

Privately held Exogene uses genetic methods to improve production strains of the aerobic microbes used to produce therapeutics, including antibiotics, proteins and amino acids. The company hopes to combine this expertise with the inexpensive fermentation methods used by agroprocessors.